Toronto, Ontario, Sept. 30, 2023 (GLOBE NEWSWIRE) -- In the heart of Canada, where the land stretches far and wide, LifeLabs is fostering a legacy of compassion and support for Indigenous communities. As we reflect and commemorate the National Day for Truth and Reconciliation, it's a moment to celebrate LifeLabs' impact over the past three decades, serving approximately 200 Indigenous communities across Canada with high-quality and... ❯❯❯
SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2023, being held November 10-15, 2023, at the San Diego Convention Center in San Diego, California. Below is the list of accepted abstracts, with links to each: ... ❯❯❯
BANNOCKBURN, Ill., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2023 on Wednesday, October 25, 2023 before the market opens. In conjunction, the management team will host a conference call to review... ❯❯❯
The data hub provides policymakers and advocates with insights into the demographics and history of people seeking treatment to inform the regulatory future of virtual OUD careBOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Bicycle Health, the nation’s largest provider of virtual opioid addiction treatment, today published population-level data on over 13,000 people who applied for Medication for Opioid Use Disorder (MOUD) Treatment in... ❯❯❯
LINCOLN, Neb., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NRC Health is pleased to announce that Lurie Children’s Hospital of Chicago has expanded their long-time partnership to include NRC Health’s Market Insights, the nation’s most comprehensive and longest-running syndicated study of consumer perceptions in healthcare. As a valued partner utilizing NRC’s patient experience technology and expertise, Lurie Children’s has expanded their... ❯❯❯
NORCROSS, Ga., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today announced it will participate in the 20th edition of the Discovery on Target meeting, the industry’s preeminent event on Novel Drug Targets and Technologies. The Company will present an update on its belapectin liver cirrhosis program during the Fibrosis and Inflammation... ❯❯❯
PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 26 September 2023, 07:00 CEST BIOCARTIS ANNOUNCES H1 2023 RESULTS AND PROVIDES AN UPDATE ON THE OPERATIONAL REORGANIZATION AND RECAPITALIZATION Company will host a conference call with live webcast presentation today at 14:30 CEST / 13:30 BST (UK) / 08:30 EDT (US) to discuss H1 2023 results Solid performance with 22% growth of oncology cartridge revenue, a 40% gross margin... ❯❯❯
PRESS RELEASE:INSIDE INFORMATION / REGULATED INFORMATION 26 September 2023, 07:00 CEST AGREEMENT REGARDING RECAPITALIZATION OF OPERATING SUBSIDIARIES BY SECURED CREDITORS AND WIND DOWN OF LISTED HOLDING COMPANY The Company’s Secured Creditors (being its First Lien Creditors and Bondholders, as defined below) will take ownership of the Biocartis operating subsidiaries through enforcement and inject EUR 40 million of new equity... ❯❯❯
TEXARKANA, Ark., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Ark-la-Tex Health Center is now offering a revolutionary new method in healing, called “regenerative medicine”. Under the expert guidance of Dr. James Raker and his dedicated staff, this once thought of science fiction type medical approach, has now become a real life beacon of hope and healing for countless individuals in the Texarkana region. Dr. James Raker leads a team of... ❯❯❯
PRESS RELEASE REGULATED INFORMATION 21 September 2023, 07:00 CEST BIOCARTIS 2023 HALF-YEAR RESULTS WEBCAST ON 26 SEPTEMBER 2023 Mechelen, Belgium, 21 September 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), will report its 2023... ❯❯❯